Atrás
Rango del Día
$6.58
$8.77
Rango de 52 Semanas
$5.30
$25.00
Volumen
138,671
Promedio 50D / 200D
$9.76
/
$12.68
Cierre Anterior
$6.49
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -386.2 | 0.4 |
| P/B | 82.7 | 2.9 |
| ROE % | -42.7 | 3.9 |
| Net Margin % | -276.6 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Earnings declined -10509.73% over the past year
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -4.75M
PEG of 0.00 suggests growth is underpriced
Capital intensive — 570.38% of revenue goes to capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)45.76%
Earnings (1Y)-10509.73%
FCF Growth (3Y)N/A
Calidad
Return on Equity
-42.69%
ROIC-16.58%
Net Margin-276.58%
Op. Margin-286.45%
Seguridad
Debt / Equity
0.00
Current Ratio13.18
Interest Coverage-1893.69
Valoración
P/E Ratio
-386.19
P/B Ratio82.72
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 45.76% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -10509.73% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 510,360.0 | Net Income (TTM) | -1.41M |
| ROE | -42.69% | ROA | -20.56% |
| Gross Margin | 30.44% | Operating Margin | -286.45% |
| Net Margin | -276.58% | Free Cash Flow (TTM) | -4.75M |
| ROIC | -16.58% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 13.18 |
| Interest Coverage | -1893.69 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -386.19 | P/B Ratio | 82.72 |
| P/S Ratio | 1068.13 | PEG Ratio | 0.00 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 545.13M | Enterprise Value | 542.02M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 510,360.0 | 350,131.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -1.41M | 13,560.0 | 3.79M | 8.70M | -2.54M |
| EPS (Diluted) | -0.56 | 0.00 | 0.41 | 0.59 | -0.17 |
| Gross Profit | 155,356.0 | 153,445.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -1.46M | -9,847.0 | -2.32M | -1.72M | -344,223.0 |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 6.86M | 321,212.0 | 17.93M | 118.06M | 117.59M |
| Total Liabilities | 273,980.0 | 298,218.0 | 6.74M | 9.11M | 17.81M |
| Shareholders' Equity | 6.59M | 22,994.0 | 11.20M | 108.96M | 99.78M |
| Total Debt | 22,555.0 | 47,576.0 | 0.0 | 0.0 | 0.0 |
| Cash & Equivalents | 3.13M | 87,098.0 | 14,129.0 | 5,403.0 | 693,818.0 |
| Current Assets | 3.47M | 271,724.0 | 202,705.0 | 129,560.0 | 830,767.0 |
| Current Liabilities | 263,060.0 | 298,218.0 | 5.55M | 2.00M | 302,219.0 |